BOOTHBAY FUND MANAGEMENT, LLC - REATA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P903. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,296,000
-60.5%
133
-36.7%
0.08%
-65.2%
Q2 2020$3,277,000
+368.8%
210
+141.4%
0.22%
+250.0%
Q3 2019$699,000
-47.6%
87
-46.6%
0.06%
-51.5%
Q3 2018$1,333,000–163–0.13%–
 Download
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Prosight Management, LP 12,300$988,0000.55%
BOOTHBAY FUND MANAGEMENT, LLC 87$699,0000.06%
SIMPLEX TRADING, LLC 157$1,260,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 400$32,0000.00%
View complete list of REATA PHARMACEUTICALS INC shareholders